Duan Y - Search Results

1

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.

Zhang D, Duan Y, Cun J, Yang Q. Zhang D, et al. Among authors: duan y. Front Genet. 2019 Mar 28;10:278. doi: 10.3389/fgene.2019.00278. eCollection 2019. Front Genet. 2019. PMID: 30984247 Free PMC article.

2

Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.

Duan Y, Zhang D. Duan Y, et al. J Cell Biochem. 2020 Jan;121(1):672-689. doi: 10.1002/jcb.29314. Epub 2019 Aug 12. J Cell Biochem. 2020. PMID: 31407370

3

Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.

Zhang D, Duan Y, Wang Z, Lin J. Zhang D, et al. Among authors: duan y. Oncol Rep. 2019 Dec;42(6):2450-2472. doi: 10.3892/or.2019.7342. Epub 2019 Sep 27. Oncol Rep. 2019. PMID: 31578577 Free PMC article.

4

A five-gene signature predicts overall survival of patients with papillary renal cell carcinoma.

Gao Z, Zhang D, Duan Y, Yan L, Fan Y, Fang Z, Liu Z. Gao Z, et al. Among authors: duan y. PLoS One. 2019 Mar 1;14(3):e0211491. doi: 10.1371/journal.pone.0211491. eCollection 2019. PLoS One. 2019. PMID: 30822312 Free PMC article.

5

Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer.

Zhang H, Zhang N, Liu Y, Su P, Liang Y, Li Y, Wang X, Chen T, Song X, Sang Y, Duan Y, Zhang J, Wang L, Chen B, Zhao W, Guo H, Liu Z, Hu G, Yang Q. Zhang H, et al. Among authors: duan y. Cancer Res. 2019 Jul 1;79(13):3347-3359. doi: 10.1158/0008-5472.CAN-18-3418. Epub 2019 Apr 2. Cancer Res. 2019. PMID: 30940661

6

Identification and preservation of stained non-sentinel lymph nodes in breast cancer.

Li X, Chen S, Duan Y, Guo H, Jiang L, Kong X, Ma T, Yang Q. Li X, et al. Among authors: duan y. Oncol Lett. 2020 Dec;20(6):373. doi: 10.3892/ol.2020.12236. Epub 2020 Oct 21. Oncol Lett. 2020. PMID: 33154771 Free PMC article.

7

A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer.

Liang Y, Song X, Li Y, Sang Y, Zhang N, Zhang H, Liu Y, Duan Y, Chen B, Guo R, Zhao W, Wang L, Yang Q. Liang Y, et al. Among authors: duan y. Cell Death Dis. 2018 May 1;9(5):563. doi: 10.1038/s41419-018-0582-1. Cell Death Dis. 2018. PMID: 29752439 Free PMC article.

8

LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215.

Kong X, Duan Y, Sang Y, Li Y, Zhang H, Liang Y, Liu Y, Zhang N, Yang Q. Kong X, et al. Among authors: duan y. J Cell Physiol. 2019 Jun;234(6):9105-9117. doi: 10.1002/jcp.27587. Epub 2018 Oct 26. J Cell Physiol. 2019. PMID: 30362551

9

Targeting the circBMPR2/miR-553/USP4 Axis as a Potent Therapeutic Approach for Breast Cancer.

Liang Y, Song X, Li Y, Ma T, Su P, Guo R, Chen B, Zhang H, Sang Y, Liu Y, Duan Y, Zhang N, Li X, Zhao W, Wang L, Yang Q. Liang Y, et al. Among authors: duan y. Mol Ther Nucleic Acids. 2019 Sep 6;17:347-361. doi: 10.1016/j.omtn.2019.05.005. Epub 2019 May 22. Mol Ther Nucleic Acids. 2019. PMID: 31302495 Free PMC article.

10

circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer.

Liang Y, Song X, Li Y, Su P, Han D, Ma T, Guo R, Chen B, Zhao W, Sang Y, Zhang N, Li X, Zhang H, Liu Y, Duan Y, Wang L, Yang Q. Liang Y, et al. Among authors: duan y. Oncogene. 2019 Oct;38(42):6850-6866. doi: 10.1038/s41388-019-0926-z. Epub 2019 Aug 12. Oncogene. 2019. PMID: 31406252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,546 results

Search Page

Filters